Pi‐Xiao Wang

2.3k total citations
27 papers, 1.3k citations indexed

About

Pi‐Xiao Wang is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Pi‐Xiao Wang has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Epidemiology and 10 papers in Immunology. Recurrent topics in Pi‐Xiao Wang's work include Liver Disease Diagnosis and Treatment (11 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Cancer-related molecular mechanisms research (5 papers). Pi‐Xiao Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Cancer-related molecular mechanisms research (5 papers). Pi‐Xiao Wang collaborates with scholars based in China, Macao and United States. Pi‐Xiao Wang's co-authors include Hongliang Li, Xiao‐Jing Zhang, Yan‐Xiao Ji, Xi Jiang, Zan Huang, Song Tian, Xue‐Yong Zhu, Ke‐Qiong Deng, Guang‐Nian Zhao and Zhi‐Gang She and has published in prestigious journals such as Nature Medicine, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Pi‐Xiao Wang

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pi‐Xiao Wang China 21 604 553 297 280 196 27 1.3k
Xue‐Yong Zhu China 25 710 1.2× 429 0.8× 296 1.0× 227 0.8× 220 1.1× 36 1.4k
Ryan E. Feaver United States 14 426 0.7× 339 0.6× 154 0.5× 208 0.7× 102 0.5× 17 1.1k
Adrien Guillot Germany 20 491 0.8× 919 1.7× 340 1.1× 150 0.5× 69 0.4× 52 1.7k
Howard C. Masuoka United States 17 1.0k 1.7× 586 1.1× 116 0.4× 429 1.5× 76 0.4× 35 1.9k
Morgane Baron France 9 422 0.7× 484 0.9× 264 0.9× 75 0.3× 79 0.4× 16 986
Christian D. Fingas Germany 22 653 1.1× 447 0.8× 191 0.6× 206 0.7× 76 0.4× 37 1.7k
Roger van Kruchten Netherlands 14 387 0.6× 342 0.6× 296 1.0× 78 0.3× 325 1.7× 18 1.6k
Adel Hammoutène France 9 279 0.5× 496 0.9× 109 0.4× 127 0.5× 54 0.3× 14 796
Anne Loft Denmark 17 766 1.3× 349 0.6× 113 0.4× 77 0.3× 59 0.3× 27 1.3k

Countries citing papers authored by Pi‐Xiao Wang

Since Specialization
Citations

This map shows the geographic impact of Pi‐Xiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pi‐Xiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pi‐Xiao Wang more than expected).

Fields of papers citing papers by Pi‐Xiao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pi‐Xiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pi‐Xiao Wang. The network helps show where Pi‐Xiao Wang may publish in the future.

Co-authorship network of co-authors of Pi‐Xiao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pi‐Xiao Wang. A scholar is included among the top collaborators of Pi‐Xiao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pi‐Xiao Wang. Pi‐Xiao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Pi‐Xiao, Ling Zhu, Mei Xiang, et al.. (2025). FTO Alleviates Hepatic Ischemia‐Reperfusion Injury by Regulating Apoptosis and Autophagy. Gastroenterology Research and Practice. 2025(1). 5587859–5587859. 1 indexed citations
2.
Wang, Pi‐Xiao, Mei Xiang, Ling Zhu, et al.. (2024). ALKBH5 Protects Against Hepatic Ischemia–Reperfusion Injury by Regulating YTHDF1-Mediated YAP Expression. International Journal of Molecular Sciences. 25(21). 11537–11537. 1 indexed citations
3.
Zhang, Rixin, et al.. (2022). Caudodorsal approach combined with in situ split for laparoscopic right posterior sectionectomy. Surgical Endoscopy. 37(2). 1334–1341. 3 indexed citations
4.
Xiang, Mei, Feiyan Yang, Yi Zhou, et al.. (2021). LITAF acts as a novel regulator for pathological cardiac hypertrophy. Journal of Molecular and Cellular Cardiology. 156. 82–94. 2 indexed citations
5.
Wang, Siyuan, Zhenzhen Yan, Xia Yang, et al.. (2017). Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver. Hepatology. 67(4). 1320–1338. 50 indexed citations
6.
Liu, Hui, Wenlin Cheng, Xi Jiang, et al.. (2017). Ablation of Interferon Regulatory Factor 3 Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice. Hypertension. 69(3). 510–520. 33 indexed citations
7.
Zhang, Yaxing, Xiao‐Jing Zhang, Pi‐Xiao Wang, Peng Zhang, & Hongliang Li. (2017). Reprogramming Innate Immune Signaling in Cardiometabolic Disease. Hypertension. 69(5). 747–760. 27 indexed citations
8.
Zhao, Ling‐Ping, Xiaoxiang Tian, Chenghui Yan, et al.. (2017). The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance. Hepatology. 66(3). 834–854. 34 indexed citations
9.
Zhang, Peng, Pi‐Xiao Wang, Ling‐Ping Zhao, et al.. (2017). The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis. Nature Medicine. 24(1). 84–94. 151 indexed citations
10.
Gao, Ling, Pi‐Xiao Wang, Yaxing Zhang, et al.. (2016). Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis. Journal of Hepatology. 65(1). 125–136. 41 indexed citations
11.
Wang, Pi‐Xiao, Peng Zhang, Xiao‐Jing Zhang, et al.. (2016). DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity. Journal of Hepatology. 65(1). 113–124. 56 indexed citations
12.
Wang, Pi‐Xiao, Xiao‐Jing Zhang, Pengcheng Luo, et al.. (2016). Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling. Nature Communications. 7(1). 10592–10592. 110 indexed citations
13.
Ji, Yan‐Xiao, Peng Zhang, Xiao‐Jing Zhang, et al.. (2016). The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling. Nature Communications. 7(1). 11267–11267. 148 indexed citations
14.
Luo, Pengcheng, Pi‐Xiao Wang, Xiaojing Zhang, et al.. (2016). Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance. American Journal Of Pathology. 186(5). 1278–1292. 32 indexed citations
15.
Hu, Junfei, Xue‐Hai Zhu, Xiao‐Jing Zhang, et al.. (2015). Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury. Journal of Hepatology. 64(1). 146–159. 85 indexed citations
16.
Sun, Peng, Peng Zhang, Pi‐Xiao Wang, et al.. (2015). Mindin deficiency protects the liver against ischemia/reperfusion injury. Journal of Hepatology. 63(5). 1198–1211. 30 indexed citations
17.
Wang, Pi‐Xiao, Xiao‐Jing Zhang, & Hongliang Li. (2015). Liver capsule: IRFs in hepatocytes: Pathophysiology. Hepatology. 63(5). 1706–1706. 13 indexed citations
18.
Zhang, Shumin, Lihua Zhu, Hou‐Zao Chen, et al.. (2014). Interferon regulatory factor 9 is critical for neointima formation following vascular injury. Nature Communications. 5(1). 5160–5160. 60 indexed citations
19.
Zhang, Shumin, Lihua Zhu, Pi‐Xiao Wang, et al.. (2014). Interferon regulatory factor 3 protects against adverse neo-intima formation. Cardiovascular Research. 102(3). 469–479. 21 indexed citations
20.
Wang, Pi‐Xiao, Ran Zhang, Ling Huang, et al.. (2014). Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury. Journal of Hepatology. 62(1). 111–120. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue‐Yong Zhu Breakdown of academic impact, for papers by Ryan E. Feaver Breakdown of academic impact, for papers by Adrien Guillot Breakdown of academic impact, for papers by Howard C. Masuoka Breakdown of academic impact, for papers by Morgane Baron Breakdown of academic impact, for papers by Christian D. Fingas Breakdown of academic impact, for papers by Roger van Kruchten Breakdown of academic impact, for papers by Adel Hammoutène Breakdown of academic impact, for papers by Anne Loft
Rankless by CCL
2026